Events

This webinar will define pre-exposure prophylaxis (PrEP) for HIV and summarize the evidence of PrEP’s safety and efficacy for preventing HIV infection, focusing on populations who use substances. It will also describe research aimed at increasing access and adherence to PrEP among individuals who use methamphetamine in Seattle, WA.

The webinar is free, however, registration is required: http://bit.ly/NWATTCStekler

Presenters:
Joanne Stekler, MD, MPH
Dr. Stekler’s research centers on HIV testing and prevention. She is a national expert on HIV tests, particularly focused on acute HIV infection and point-of-care testing. She started the first community-based clinic for HIV pre-exposure prophylaxis (PrEP) in Seattle and is currently working to increase access to PrEP and PrEP adherence across Washington State.

Vanessa McMahan, MD, PhDc
Ms. McMahan’s research focuses on PrEP use among individuals who use methamphetamine. Prior to her work at the University of Washington, she coordinated the iPrEx study, which supported the FDA indication for PrEP for HIV prevention. She is also the Hepatitis C Care Advocate and a volunteer at the People’s Harm Reduction Alliance (PHRA) syringe exchange program in Seattle.